Uniqure NV (QURE) is a biotechnology company listed on NASDAQ.
Latest reported QURE revenue for 2025-12-31 was $16.1M. Net income was -$199.0M. Revenue was down 40.6% from 2024-12-31 to 2025-12-31. QURE currently screens at market cap $3.04B.
Use this QURE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the QURE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the QURE SEC filings page. Lician reads the product cache first so this HTML stays unique to Uniqure NV even when a live quote feed is slow.
Latest cached year on this hub. Full QURE income, balance, and cash tables.